Crescent Grove Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $835K | Buy |
3,415
+10
| +0.3% | +$2.33K | 0.08% | 147 |
|
|
2025
Q4 | $705K | Sell |
3,405
-18
| -0.5% | -$3.56K | 0.07% | 155 |
|
|
2025
Q3 | $635K | Sell |
3,423
-36
| -1% | -$6.17K | 0.06% | 153 |
|
|
2025
Q2 | $528K | Sell |
3,459
-511
| -13% | -$78.5K | 0.05% | 156 |
|
|
2025
Q1 | $658K | Buy |
3,970
+242
| +6% | +$37.9K | 0.07% | 140 |
|
|
2024
Q4 | $539K | Sell |
3,728
-919
| -20% | -$142K | 0.05% | 154 |
|
|
2024
Q3 | $753K | Sell |
4,647
-382
| -8% | -$60.9K | 0.08% | 134 |
|
|
2024
Q2 | $735K | Sell |
5,029
-449
| -8% | -$66.8K | 0.08% | 131 |
|
|
2024
Q1 | $867K | Sell |
5,478
-1,109
| -17% | -$177K | 0.09% | 126 |
|
|
2023
Q4 | $1.03M | Sell |
6,587
-281
| -4% | -$43.1K | 0.12% | 117 |
|
|
2023
Q3 | $1.07M | Buy |
6,868
+107
| +2% | +$17.7K | 0.13% | 107 |
|
|
2023
Q2 | $1.12M | Sell |
6,761
-397
| -6% | -$64.1K | 0.12% | 105 |
|
|
2023
Q1 | $1.11M | Buy |
7,158
+111
| +2% | +$17.9K | 0.13% | 97 |
|
|
2022
Q4 | $1.24M | Sell |
7,047
-111
| -2% | -$19.2K | 0.13% | 99 |
|
|
2022
Q3 | $1.17M | Buy |
7,158
+1,944
| +37% | +$329K | 0.14% | 82 |
|
|
2022
Q2 | $925K | Sell |
5,214
-270
| -5% | -$48.1K | 0.1% | 109 |
|
|
2022
Q1 | $972K | Sell |
5,484
-1,510
| -22% | -$257K | 0.1% | 114 |
|
|
2021
Q4 | $1.2M | Buy |
6,994
+473
| +7% | +$77.4K | 0.11% | 97 |
|
|
2021
Q3 | $1.05M | Buy |
6,521
+1,074
| +20% | +$183K | 0.11% | 99 |
|
|
2021
Q2 | $897K | Buy |
5,447
+132
| +2% | +$21.9K | 0.09% | 112 |
|
|
2021
Q1 | $873K | Buy |
5,315
+422
| +9% | +$68.3K | 0.1% | 102 |
|
|
2020
Q4 | $770K | Buy |
4,893
+50
| +1% | +$7.38K | 0.1% | 87 |
|
|
2020
Q3 | $721K | Sell |
4,843
-46
| -0.9% | -$6.81K | 0.14% | 78 |
|
|
2020
Q2 | $687K | Sell |
4,889
-99
| -2% | -$14.4K | 0.15% | 74 |
|
|
2020
Q1 | $654K | Buy |
4,988
+94
| +2% | +$13.3K | 0.15% | 65 |
|
|
2019
Q4 | $714K | Buy |
4,894
+1
| +0% | +$136 | 0.12% | 81 |
|
|
2019
Q3 | $633K | Hold |
4,893
| – | – | 0.12% | 78 |
|
|
2019
Q2 | $681K | Buy |
4,893
+169
| +4% | +$23.4K | 0.13% | 76 |
|
|
2019
Q1 | $660K | Sell |
4,724
-1,968
| -29% | -$264K | 0.14% | 77 |
|
|
2018
Q4 | $864K | Buy |
6,692
+18
| +0.3% | +$2.51K | 0.18% | 69 |
|
|
2018
Q3 | $922K | Buy |
6,674
+1
| +0% | +$133 | 0.2% | 60 |
|
|
2018
Q2 | $810K | Hold |
6,673
| – | – | 0.2% | 63 |
|
|
2018
Q1 | $855K | Buy |
6,673
+222
| +3% | +$30K | 0.21% | 59 |
|
|
2017
Q4 | $901K | Sell |
6,451
-185
| -3% | -$25.8K | 0.23% | 55 |
|
|
2017
Q3 | $863K | Hold |
6,636
| – | – | 0.22% | 57 |
|
|
2017
Q2 | $878K | Buy |
+6,636
| New | +$847K | 0.25% | 52 |
|
Other funds holding JNJ
VCM
VPM
Crescent Grove Advisors's JNJ Position: Q1 2026 in Review
Crescent Grove Advisors increased its Johnson & Johnson (JNJ) stake by 0.29% in Q1 2026, buying an estimated $2.33K and bringing the position to 3,415 shares worth $835K. The position accounts for 0.08% of the portfolio, ranked #147.
Crescent Grove Advisors first reported a position in JNJ in Q2 2017 and has held it in 36 quarters since. The position peaked at $1.24M in Q4 2022. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Crescent Grove Advisors held 3,415 shares of Johnson & Johnson worth $835K as of Q1 2026.
- Crescent Grove Advisors bought 10 Johnson & Johnson shares in Q1 2026, an estimated $2.33K.
- Johnson & Johnson made up 0.08% of Crescent Grove Advisors's portfolio in Q1 2026, its #147 holding.
- Crescent Grove Advisors first reported a position in Johnson & Johnson in Q2 2017 and has held it in 36 quarters since.
- Crescent Grove Advisors's Johnson & Johnson position peaked at $1.24M in Q4 2022.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Crescent Grove Advisors's 13F filing for Q1 2026, filed 6 May 2026.